Acute Otitis Media: Diagnosis Criteria, Watchful Waiting vs Antibiotics and the Dosing the Exam Expects

Acute otitis media (AOM) on the FNP exam is three decisions in a row: is this really AOM, does this child need antibiotics now or can the family wait 48 to 72 hours, and if treating, which drug at which dose for how long. The AAP 2013 guideline (Lieberthal and colleagues) answers all three: diagnosis needs bulging of the tympanic membrane or new otorrhea, the antibiotic-versus-observation choice depends on age, severity and laterality, and first-line therapy is high-dose amoxicillin at 80 to 90 mg/kg/day in 2 divided doses. The guideline covers children 6 months through 12 years; infants younger than 6 months fall outside it and are not candidates for observation.

Assessment

History

Ask about the onset and duration of ear pain (in a nonverbal child, holding, tugging or rubbing the ear), the highest temperature in the past 48 hours, irritability, poor sleep and feeding, and recent upper respiratory infection. Then ask the history that changes the drug choice: amoxicillin in the past 30 days, eye discharge, prior AOM and response to treatment, and penicillin allergy with the type of reaction. Record risk factors that the provider will address in education: daycare attendance, tobacco smoke exposure, pacifier use, bottle propping and incomplete immunizations.

Otoscopy

The diagnosis is made at the otoscope, not from symptoms. Symptoms of AOM overlap almost completely with those of a viral upper respiratory infection. Clear cerumen if it blocks the view. The guideline states that AOM should not be diagnosed without middle ear effusion, confirmed by pneumatic otoscopy, tympanometry or both.

Diagnostic criteria

Bulging is the single finding with the best predictive value. An opaque, immobile membrane with an air-fluid level and no bulging describes otitis media with effusion (OME), which is a different disease with different management.

Antibiotics or observation

The guideline defines severe AOM as moderate or severe otalgia, otalgia for at least 48 hours, or temperature of 39 C (102.2 F) or higher. Table 4 of the guideline also treats a toxic-appearing child and uncertain access to follow-up as reasons to treat.

Observation is a shared decision with the caregiver, not a default. When chosen, there must be a reliable way to start antibiotics if the child worsens or fails to improve within 48 to 72 hours of symptom onset: a "wait-and-see" prescription to fill only if needed, or a scheduled recheck or phone contact. If follow-up cannot be assured, prescribe.

Pain control comes first in every pathway

The guideline makes pain assessment and treatment a strong recommendation regardless of the antibiotic decision. Acetaminophen or ibuprofen at weight-based doses is the standard. Antibiotics do not relieve pain in the first 24 hours, so analgesia is needed even in children who are treated.

Drug choice and dosing

High-dose amoxicillin is chosen because it reaches middle ear concentrations that overcome intermediate penicillin resistance in Streptococcus pneumoniae. The clavulanate formulation adds beta-lactamase coverage for nontypeable H influenzae and Moraxella catarrhalis, which is why recent amoxicillin exposure and the otitis-conjunctivitis syndrome shift the choice. Azithromycin and trimethoprim-sulfamethoxazole are not on the guideline's recommended list because of pneumococcal resistance.

Duration

Monitoring and treatment failure

Reassess any child whose caregiver reports worsening or no improvement within 48 to 72 hours, whether the child was observed or treated. Confirm the diagnosis on re-examination, then escalate: an observed child starts amoxicillin, and a child who failed amoxicillin moves to amoxicillin-clavulanate or ceftriaxone. A routine ear recheck at 10 days is not required in a child who is well; the guideline notes that middle ear effusion persists after treatment in many children and does not by itself mean failure.

Recurrent AOM and prevention

Recurrent AOM is defined as 3 episodes in 6 months, or 4 episodes in 1 year with 1 in the preceding 6 months. The AAP 2013 guideline advises against prophylactic antibiotics for recurrent AOM and lists tympanostomy tubes as an option. The 2022 tympanostomy tube guideline narrows that: tubes are offered for recurrent AOM only when middle ear effusion is present at the time of assessment for candidacy.

Prevention recommendations in the AAP guideline are pneumococcal conjugate vaccine and annual influenza vaccine per the routine schedule, exclusive breastfeeding for at least 6 months, and avoiding tobacco smoke exposure. Avoiding bottle propping and limiting pacifier use after infancy are reasonable additions in counseling.

Otitis media with effusion: the AAP-endorsed 2016 update

OME is fluid in the middle ear without signs of acute infection. It commonly follows AOM or a cold and usually resolves on its own. The 2016 guideline, developed with the AAP and AAFP, sets these rules:

• Use pneumatic otoscopy to diagnose; obtain tympanometry when the diagnosis is uncertain.
• Identify at-risk children (for example permanent hearing loss, speech or language delay, autism spectrum disorder, Down syndrome, craniofacial anomalies including cleft palate, and blindness) and evaluate them for OME at the time the risk condition is diagnosed and at 12 to 18 months of age.
• Do not screen healthy, asymptomatic children for OME.
• Manage a child who is not at risk with watchful waiting for 3 months from the onset of effusion, or from diagnosis if the onset is unknown.
• Recommend against intranasal or systemic steroids, systemic antibiotics, and antihistamines or decongestants.
• Obtain an age-appropriate hearing test if OME persists for 3 months or longer, or at any duration in an at-risk child.
• Reevaluate chronic OME at 3 to 6 month intervals until the effusion clears, significant hearing loss is found, or structural changes of the eardrum are suspected.
• When surgery is performed in a child younger than 4 years, tympanostomy tubes are the procedure; adenoidectomy is added only for a separate indication. At 4 years and older, tubes, adenoidectomy or both are options.

Referral triggers

Refer urgently for signs of acute mastoiditis (postauricular swelling, tenderness and protrusion of the auricle), facial nerve palsy, meningeal signs, or a toxic appearance. Refer to otolaryngology for failure of a second antibiotic, recurrent AOM meeting the definition with persistent effusion, chronic OME with hearing loss or at-risk status, a retraction pocket or cholesteatoma, or persistent perforation with drainage.

Caregiver education

• Explain that most AOM improves within 2 to 3 days, and that observation is safe only with the agreed follow-up plan.
• Give the analgesic plan with weight-based doses and a schedule.
• Complete the full antibiotic course; expect diarrhea and diaper rash with amoxicillin-clavulanate and taking it with food can help.
• Return for fever that persists after 48 to 72 hours of treatment, worsening pain, swelling behind the ear, stiff neck or lethargy.
• Fluid behind the eardrum can last weeks after the infection clears and does not mean the antibiotic failed.
• Keep vaccines current, avoid smoke exposure and do not prop bottles.

How the exam tests this

• Red ear trap: a crying child with a red but non-bulging membrane is not AOM.
• Age-laterality trap: a 15-month-old with mild bilateral AOM is treated, while a 15-month-old with mild unilateral AOM may be observed. Candidates often reverse these.
• Severity numbers: temperature 39 C (102.2 F) and otalgia for 48 hours define severe disease.
• Dose trap: standard-dose amoxicillin at 40 to 45 mg/kg/day is wrong; the exam expects 80 to 90 mg/kg/day.
• Recent-amoxicillin trap: a child treated with amoxicillin 3 weeks ago needs amoxicillin-clavulanate, not a repeat course.
• Allergy trap: azithromycin is a tempting but non-recommended choice; the guideline lists cefdinir, cefuroxime, cefpodoxime or ceftriaxone.
• OME trap: persistent effusion after AOM treated with another antibiotic, a steroid or a decongestant is wrong; the answer is watchful waiting and a hearing test at 3 months.

Practice question

A 20-month-old girl has had fever and fussiness for 1 day. Her highest temperature was 38.4 C (101.1 F). She is pulling at both ears and sleeping poorly. She attends daycare and completed a 10-day course of amoxicillin for AOM 3 weeks ago. Examination shows moderately bulging, opaque tympanic membranes with decreased mobility on both sides. She has no eye discharge and no drug allergies. Which plan is most appropriate?

• A. Observation for 48 to 72 hours with ibuprofen and a scheduled phone follow-up.
• B. Amoxicillin 45 mg/kg/day in 2 divided doses for 10 days.
• C. Amoxicillin-clavulanate, 90 mg/kg/day of the amoxicillin component in 2 divided doses for 10 days, plus analgesia.
• D. Azithromycin daily for 5 days plus analgesia.

Answer: C. This child has true AOM (moderate bulging with effusion) and received amoxicillin within the past 30 days, which calls for added beta-lactamase coverage with high-dose amoxicillin-clavulanate, and her age under 2 years sets a 10-day course. Option A is wrong because bilateral AOM in a child 6 to 23 months old requires antibiotics even when symptoms are nonsevere; observation at this age is reserved for nonsevere unilateral disease. Option B uses a standard dose that does not overcome resistant pneumococcus and repeats a drug that recently failed to prevent recurrence. Option D is not a recommended agent because of pneumococcal resistance.

Key points

Related NPPace guides

• Contraception by Medical Condition: Using the US MEC on the FNP Exam
• Menopause Symptom Management: Who Can Have Hormone Therapy, Who Cannot and the Nonhormone Options
• Prenatal Care for the FNP Exam: Visit Schedule, Labs by Trimester and the Numbers to Know
• How to Read a Primary-Care Vignette Like a Provider: The 5-Step Method
• AANP vs ANCC: Which NP Certification Exam Should You Take?